|
EQS-Ad-hoc: SHOP APOTHEKE EUROPE NV / Key word(s): Joint Venture/Capital Increase 11.05.2023 / 19:14 CET/EST SHOP APOTHEKE EUROPE and GALENICA: Antitrust approvals received for joint venture |
The base prospectus as well as the final terms and the basic information sheets can be obtained by clicking on the disclaimer document. Also note the further hints to this advertisement.
Sevenum, The Netherlands, May 11, 2023. Redcare Pharmacy NV (formerly SHOP APOTHEKE EUROPE NV) and GALENICA AG announce that they have received approval from the responsible antitrust authorities for the establishment of their announced joint venture in the Swiss market (“transaction“) have received.
The antitrust authorities’ approvals were necessary conditions for the implementation of the transactionunder which the business activities of shop-apotheke.ch and Spezialapotheke Mediservice AG will be merged into a joint company.
With the granting of the release, the transaction will now be completed as planned at short notice, presumably on May 16, 2023. The capital increase required as part of the transaction is to be carried out by the end of June 2023 at the latest.
Ende der Insider information
05/11/2023 CET/CEST The EQS distribution services include statutory reporting requirements, corporate news/financial news and press releases.
Media archive at https://eqs-news.com
|
Language: |
Deutsch |
|
Company: |
SHOP PHARMACY EUROPE NV |
|
Erik de Rodeweg 11-13 |
|
|
5975 WD Sevenum |
|
|
Netherlands |
|
|
Telephone: |
0800 – 200 800 300 |
|
Fax: |
0800 – 90 70 90 20 |
|
E-Mail: |
|
|
Internet: |
www.shop-apotheke-europe.com |
|
ISIN: |
NL0012044747, DE000A19Y072 |
|
WKN: |
A2AR94, A19Y07 |
|
indices: |
SDAX |
|
The stock exchange: |
Regulated market in Frankfurt (Prime Standard); Open market in Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
|
EQS News ID: |
1631243 |
|
end of message |
EQS News-Service |
1631243 11.05.2023 CET/CEST